Fluoropyrimidine chemotherapy: recommendations for DPYD genotyping and therapeutic drug monitoring of the Swiss Group of Pharmacogenomics and Personalised Therapy. Swiss Med Wkly [Internet]. 2020 Nov. 24 [cited 2025 Dec. 13];150(4748):w20375. Available from: https://www.smw.ch/index.php/smw/article/view/2899